One of the main targets of Pharmathen S.A. the last few years is the research and development of new generic products. Through the design and development of new products according to the current legislation, the implementation of products that fulfil the needs of customers and patients alike is achieved.

Pharmathen ensures the provision of products according to the expectations of its clients as well as the legal and regulative requirements by cooperating with the largest manufacturers of raw materials, working in parallel with Universities and National Research Centers in development of medicines, applying the chemical and pharmaceutical rules of development according with the European standards, conducting bioequivalence studies in recognized CRO (Contract Research Organisations) and having its products approved all over the world.

Several teams of specialized scientists are dealing with the continuous improvement and support of the products, from the moment of design until the submission and launching of the product to the market.

Pharmathen is committed to produce products of the highest quality and to offer excellent customer support. Our Integrated services have established innovative practices and techniques in order to fulfil those targets to the highest standard. These services include the departments of Quality Assurance, Regulatory Affairs Department, Quality Control, Research and Development and Production.

General

Quality Assurance

Regulatory Affairs

Quality Control

Production